Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 3819502, 7 pages
https://doi.org/10.1155/2017/3819502
Research Article

HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus

Department of Traditional Chinese Medicine, Beijing Ditan Hospital and Collaborative Innovation Center of Infectious Diseases, Capital Medical University, Chaoyang, Beijing 100015, China

Correspondence should be addressed to Zhiyun Yang; moc.361@66nuyihzgnay

Received 11 November 2016; Revised 28 November 2016; Accepted 12 December 2016; Published 5 January 2017

Academic Editor: Chun Gao

Copyright © 2017 Lingling He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Njei, Y. Rotman, I. Ditah, and J. K. Lim, “Emerging trends in hepatocellular carcinoma incidence and mortality,” Hepatology, vol. 61, no. 1, pp. 191–199, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Schlesinger, K. Aleksandrova, T. Pischon et al., “Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European Cohort,” Annals of Oncology, vol. 24, no. 9, pp. 2449–2455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. T. M. Welzel, B. I. Graubard, S. Quraishi et al., “Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States,” American Journal of Gastroenterology, vol. 108, no. 8, pp. 1314–1321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Zheng, C. Zhang, J. Yan et al., “Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area,” PLoS ONE, vol. 8, no. 12, Article ID e84776, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Gao, H.-C. Zhao, J.-T. Li, and S.-K. Yao, “Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis,” World Journal of Gastroenterology, vol. 16, no. 35, pp. 4467–4475, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. V. W.-S. Wong, S. L. Chan, F. Mo et al., “Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers,” Journal of Clinical Oncology, vol. 28, no. 10, pp. 1660–1665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Yang, M. Yuen, H. L. Chan et al., “Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score,” The Lancet Oncology, vol. 12, no. 6, pp. 568–574, 2011. View at Publisher · View at Google Scholar
  9. G. L.-H. Wong, H. L.-Y. Chan, C. K.-Y. Wong et al., “Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B,” Journal of Hepatology, vol. 60, no. 2, pp. 339–345, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Michikawa, M. Inoue, N. Sawada et al., “Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-Based Prospective Study Cohort II,” Preventive Medicine, vol. 55, no. 2, pp. 137–143, 2012. View at Google Scholar
  11. J. A. Flemming, J. D. O. Yang, E. Vittinghoff, W. R. Kim, and N. A. Terrault, “Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model,” Cancer, vol. 120, no. 22, pp. 3485–3493, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-H. Chiang, C.-W. Lu, H.-C. Han et al., “The relationship of diabetes and smoking status to hepatocellular carcinoma mortality,” Medicine, vol. 95, no. 6, Article ID e2699, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-G. Wang, P. Wang, B. Wang, Z.-J. Fu, W.-J. Zhao, and S.-L. Yan, “Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 5, Article ID e95485, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-Y. Wang, S. Huang, J.-H. Zhong et al., “Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy,” PLoS ONE, vol. 9, no. 12, Article ID e113858, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Zhang, X. Li, X. Zhang, Y. Yang, Z. Feng, and X. Liu, “association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer,” Molecular and Clinical Oncology, vol. 2, no. 4, pp. 506–508, 2014. View at Publisher · View at Google Scholar
  17. M. P. Bancks, A. O. Odegaard, J. S. Pankow et al., “Glycated hemoglobin and all-cause and cause-specific mortality in Singaporean Chinese without diagnosed diabetes: the Singapore Chinese Health Study,” Diabetes Care, vol. 37, no. 12, pp. 3180–3187, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. K.-T. Khaw, N. Wareham, R. Luben et al., “Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investagation of Cancer and Nutrition (EPIC-Norfolk),” British Medical Journal, vol. 322, no. 7277, pp. 15–18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. G.-C. Zhong, M.-X. Ye, J.-H. Cheng, Y. Zhao, and J.-P. Gong, “HbA1c and risks of all-cause and cause-specific death in subjects without known diabetes: a dose-response meta-analysis of prospective cohort studies,” Scientific Reports, vol. 6, Article ID 24071, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Sluik, H. Boeing, J. Montonen et al., “HbA 1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus,” PLoS ONE, vol. 7, no. 6, Article ID e38877, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. K. Cheon, J. K. Koo, Y. S. Lee, T. Y. Lee, and C. S. Shim, “Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes,” Gut and Liver, vol. 8, no. 2, pp. 205–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Erickson, R. E. Patterson, S. W. Flatt et al., “Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer,” Journal of Clinical Oncology, vol. 29, no. 1, pp. 54–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-K. Xiao, D. Chen, S.-Q. Li, S.-J. Fu, B.-G. Peng, and L.-J. Liang, “Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis,” BMC Cancer, vol. 14, no. 1, article 117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Ji, Y. Liang, S.-J. Fu et al., “A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: The neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI),” BMC Cancer, vol. 16, article 137, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Liao, J. Zhang, Q. Zhu et al., “Preoperative neutrophil-to-lymphocyte ratio as a new prognostic marker in hepatocellular carcinoma after curative resection,” Translational Oncology, vol. 7, no. 2, pp. 248–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. G.-Q. Huang, G.-Q. Zhu, Y.-L. Liu et al., “Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection,” Oncotarget, vol. 7, no. 5, pp. 5429–5439, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-J. Yang, Z. Guo, Y.-T. Yang et al., “Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: a propensity score-based analysis,” World Journal of Gastroenterology, vol. 22, no. 21, pp. 5088–5095, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Zhang, L. Ye, J. Zhang et al., “MELD scores and child-pugh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholithiasis: a retrospective cohort study,” Medicine (United States), vol. 94, no. 3, p. e433, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. K. A. Attia, K. C. Ackoundou-N'guessan, A. T. N'dri-yoman et al., “Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients,” World Journal of Gastroenterology, vol. 14, no. 2, pp. 286–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Angermayr, M. Cejna, F. Karnel et al., “Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt,” Gut, vol. 52, no. 6, pp. 879–885, 2003. View at Publisher · View at Google Scholar · View at Scopus